Audrey is a Senior Associate at Forbion and joined the team in 2021. At Forbion, Audrey focuses on the firms’ Growth Opportunities Fund concentrating on private growth capital, European cross over financing and under-valued public companies. Audrey started her career with Kurma Partners, a well-known venture capital firm based in Paris, specialized in the financing of innovation in healthcare and biotechnology. Prior to joining Forbion, Audrey was an Associate with Bpifrance – Large Venture, the Growth fund managed by the French Sovereign Wealth Fund. Audrey received her MSc in Biology from Université de Technologie de Compiègne (France) and is a graduate of ESCP Europe with a major in Biopharmaceutical Management.
Search here
Categories
Recent Posts
Anaveon presents clinical trial OMNIA-2 at the American Society of Clinical Oncology 2023 Annual Meeting
June 5, 2023Anaveon Presents Trial in Progress Data for OMNIA-1 at the American Society of Clinical Oncology 2023 Annual Meeting
June 3, 2023Anaveon presents ANV600, a novel development compound, at the 2023 American Association for Cancer Research Annual Meeting
April 18, 2023
Popular Tags
Archives
- June 2023 2
- April 2023 1
- March 2023 2
- February 2023 1
- November 2022 2
- October 2022 1
- September 2022 1
- July 2022 3
- April 2022 1
- March 2022 1
- December 2021 1
- November 2021 1
- June 2021 1
- March 2021 1
- November 2020 1
- May 2020 1
- April 2019 1
- February 2019 1